![Matthew Kreps](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 14 061 $ al 31/07/2026
Matthew Kreps currently works at 22nd Century Group, Inc., as Head-Investor Relations & Media Contact.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Astrotech Corp.
 Astrotech Corp. Aerospace & DefenseElectronic Technology Develops, manufactures and sells trace detectors 0,11 % | 16/07/2026 | 2.150 ( 0,11 % ) | 14 061 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 22ND CENTURY GROUP, INC. | Contacto de Relaciones con Inversores | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
22nd Century Group, Inc.
 22nd Century Group, Inc. BiotechnologyHealth Technology Operates as a plant biotechnology company focused on technology that allows to increase or decrease level of nicotine and other nicotinic alkaloids in tobacco plants through genetic engineering and plant breeding | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
